NEW YORK, June 6, 2017 /PRNewswire/ -- Dr. Joan Fallon, CEO & Founder of Curemark, was named as a finalist for the EY Entrepreneur Of The Year® 2017 Award in the New York program. The awards program, which is celebrating its 31st year, recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Dr. Fallon was selected as a finalist by a panel of independent judges based on her work at Curemark, a biopharmaceutical company she founded to develop novel therapies for neurological disorders. Award winners will be announced at a special gala event on June 22, 2017 at the New York Marriott Marquis.
"It is an honor to be recognized by EY, and it is one that I share with the many individuals that through the years have enabled Curemark to grow from a mere idea around the kitchen table to a formidable biotechnology company with a late stage drug candidate for autism," said Dr. Joan Fallon, founder and CEO of Curemark. "This honor celebrates the Curemark family, which not only includes my incredibly committed team, but also our investors, our manufacturing partners, the advocacy groups, our study teams across the US and the families who step forward to advance research by participating in our clinical trials."
Curemark is conducting a Phase 3 clinical trial of its lead drug candidate, CM-AT, for autism at over 30 clinical centers across the U.S. CM-AT has received Fast Track Designation from FDA and the company has been granted a rolling review of its New Drug Application.
Now in its 31st year, the program has expanded to recognize business leaders in over 145 cities and more than 60 countries throughout the world.
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National competition. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 18, 2017. The awards are the culminating event of the Strategic Growth Forum™, the nation's most prestigious gathering of high-growth, market-leading companies.
Sponsors
Founded and produced by EY, the Entrepreneur Of The Year Awards are nationally sponsored in the US by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation.
In New York, sponsors also include Empire Valuation, Kirkland & Ellis LLP, Pine Hill Group, SolomonEdwardsGroup and DLA Piper.
About Curemark, LLC
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease. For additional information, please visit our website at http://www.curemark.com or follow @curemark on Twitter.
About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world's most prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in over 145 cities and more than 60 countries. ey.com/eoy
About EY's Growth Markets Network
EY's worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we've helped many of the world's most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/sgm or follow news on Twitter @EY_Growth.
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US.
For more information, please visit ey.com.
Advertisement
"It is an honor to be recognized by EY, and it is one that I share with the many individuals that through the years have enabled Curemark to grow from a mere idea around the kitchen table to a formidable biotechnology company with a late stage drug candidate for autism," said Dr. Joan Fallon, founder and CEO of Curemark. "This honor celebrates the Curemark family, which not only includes my incredibly committed team, but also our investors, our manufacturing partners, the advocacy groups, our study teams across the US and the families who step forward to advance research by participating in our clinical trials."
Advertisement
Curemark is conducting a Phase 3 clinical trial of its lead drug candidate, CM-AT, for autism at over 30 clinical centers across the U.S. CM-AT has received Fast Track Designation from FDA and the company has been granted a rolling review of its New Drug Application.
Now in its 31st year, the program has expanded to recognize business leaders in over 145 cities and more than 60 countries throughout the world.
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National competition. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 18, 2017. The awards are the culminating event of the Strategic Growth Forum™, the nation's most prestigious gathering of high-growth, market-leading companies.
Sponsors
Founded and produced by EY, the Entrepreneur Of The Year Awards are nationally sponsored in the US by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation.
In New York, sponsors also include Empire Valuation, Kirkland & Ellis LLP, Pine Hill Group, SolomonEdwardsGroup and DLA Piper.
About Curemark, LLC
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease. For additional information, please visit our website at http://www.curemark.com or follow @curemark on Twitter.
About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world's most prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in over 145 cities and more than 60 countries. ey.com/eoy
About EY's Growth Markets Network
EY's worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we've helped many of the world's most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/sgm or follow news on Twitter @EY_Growth.
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US.
For more information, please visit ey.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-joan-fallon-ceo-of-curemark-named-ey-entrepreneur-of-the-year-2017-award-finalist-in-new-york-300469509.html
SOURCE Curemark, LLC
